<DOC>
	<DOCNO>NCT00002884</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . It yet know whether external-beam radiation therapy plus chemotherapy effective without internal radiation therapy . PURPOSE : Randomized phase III trial compare chemotherapy external-beam radiation therapy without internal radiation therapy treat patient stage I , stage II , stage III esophageal cancer .</brief_summary>
	<brief_title>Chemotherapy Radiation Therapy Treating Patients With Cancer Esophagus</brief_title>
	<detailed_description>OBJECTIVES : I . Compare complete local remission rate patient unresectable stage I , II , III esophageal cancer treat chemoradiotherapy without endoluminal brachytherapy . II . Compare complete remission rate ( local , locoregional , distant ) patient . III . Compare overall disease-free survival patient 2 5 year therapy . IV . Compare toxicity quality life experience patient . OUTLINE : This randomize , multicenter study . Patients stratify accord participate center , tumor stage , chemotherapy . All patient receive fluorouracil IV continuously 4 day ( day 1-4 ) and/or cisplatin day 2 week 1 5 . External beam radiotherapy begin day 1 chemotherapy deliver daily fraction , 5 day per week , 5 week , follow cone dose administer week 6 . Patients randomized brachytherapy ( Iridium 192 , high-dose rate ) treat week 11 12 receive 2 additional course chemotherapy week 9 14 . Patients randomized brachytherapy receive additional chemotherapy course week 9 13 . Quality life assess . Patients follow every 6 month 2 year annually 3 year year . PROJECTED ACCRUAL : A total 326 patient accrue study .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven squamous cell carcinoma adenocarcinoma esophagus No cancer cardia Stage T1 , T2 , T3 , T4 No tumor great 7 cm No tumor diameter great 3 cm No involve node locate 3 cm tumor Supraclavicular nodal involvement eligible cervical esophageal tumor No metastasis Patient ineligible surgery one following : Condition contraindicate surgery Refusal surgery PATIENT CHARACTERISTICS : Age : 18 74 Performance status : 02 Hematopoietic : WBC least 2,000/mm3 Polymorphonuclear lymphocyte count least 1,500/mm3 Platelet count least 80,000/mm3 Hemoglobin least 10 g/dL Hepatic : Not specify Renal : Creatinine le 2.8 mg/dL Cardiovascular : No angina pectoris No history myocardial infarction No contraindication therapy EKG No cardiac contraindication chemotherapy Other : No peripheral neuropathy No second malignancy except basal cell skin cancer , carcinoma situ cervix , carcinoma remission least 2 year Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics Other : No prior laser therapy No prior electrocoagulation No prior cryotherapy No prior sclerosing injection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage I esophageal cancer</keyword>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>squamous cell carcinoma esophagus</keyword>
	<keyword>adenocarcinoma esophagus</keyword>
</DOC>